rs4840568 — BLK

Regulatory variant 2kb upstream of BLK that tags reduced B-lymphoid tyrosine kinase expression, raising risk for systemic lupus erythematosus and autoimmune thyroid disease, particularly in Asian populations

See your personal result for BLK

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

BLK rs4840568 — A Second Tag on the B-Cell Kinase Locus

BLK (B-lymphoid tyrosine kinase)11 BLK (B-lymphoid tyrosine kinase)
A Src-family non-receptor tyrosine kinase expressed almost exclusively in B cells and plasmacytoid dendritic cells is a critical regulator of B-cell receptor signaling and B-cell tolerance. rs4840568 is a 2kb-upstream variant in the same FAM167A-BLK regulatory region as the more extensively studied rs13277113, and the two variants sit roughly 1.8 kilobases apart on chromosome 8p23.1. Multiple studies have genotyped both SNPs simultaneously; in Han Chinese populations they are in strong linkage disequilibrium22 strong linkage disequilibrium
LD r²>0.9 and D′>0.9, meaning the two alleles are nearly always inherited together in East Asian populations, per Yin et al. 2021 (PMID 34637583). Despite this LD, rs4840568 shows somewhat different allele frequencies across ancestries — particularly a higher A-allele frequency in African and Latino populations than rs13277113 — suggesting it may tag additional regulatory variation or capture LD with functional elements that rs13277113 does not fully represent in non-Asian populations.

The Mechanism

Like rs13277113, rs4840568 sits in the shared promoter/enhancer region upstream of the BLK transcription start site. Variants in this region collectively modulate BLK mRNA levels in B cells: the risk haplotype carrying A alleles at both rs4840568 and rs13277113 is associated with lower BLK expression in B-cell lines, measured directly in the 2008 discovery study33 2008 discovery study
Hom et al. 2008 — BLK mRNA reduced in B-cell lines from carriers of the risk haplotype. Reduced BLK kinase activity impairs the tolerance checkpoint that normally eliminates self-reactive B-cell clones in the bone marrow, allowing autoreactive B cells to survive and produce autoantibodies — the molecular driver of SLE, Sjögren's syndrome, and related diseases.

Whether rs4840568 has independent functional effects beyond tagging the rs13277113 risk haplotype has not been resolved in functional studies. The 2021 NMOSD study44 2021 NMOSD study
Yin et al. — 310 Han Chinese individuals; rs4840568 showed no independent association with neuromyelitis optica after haplotype conditioning found no independent rs4840568 signal after accounting for the broader haplotype. Nevertheless, the variant independently appeared in a multi-phenotype GWAS55 multi-phenotype GWAS
Sakaue et al. 2021 — largest multi-trait GWAS to date, combining data across thousands of traits as a genome-wide significant hit for serum total protein levels (beta=+0.028, P=4×10⁻³³), consistent with altered immunoglobulin and immune protein output in risk-allele carriers.

The Evidence

The primary evidence anchor is the Zeng et al. 2017 meta-analysis66 Zeng et al. 2017 meta-analysis
PMID 28885337 — 33 studies total; rs4840568 analysis covered 4 studies with 11,391 SLE cases and 10,972 controls, which found rs4840568 A allele OR=1.32 (95% CI 1.22–1.43) for SLE, comparable to the rs13277113 OR of 1.33 in the same paper. An earlier Chinese case-control study77 Chinese case-control study
Chen et al. 2012 — 532 SLE cases, 576 controls; high-resolution melting genotyping found significant allele associations for both rs4840568 and rs13277113 in a Han Chinese cohort.

Beyond SLE, a Chinese AITD cohort88 Chinese AITD cohort
Song et al. 2018 — 999 autoimmune thyroid disease patients (624 Graves' disease, 375 Hashimoto's thyroiditis) and 797 controls; adolescent-focused analysis found the A allele of rs4840568 linked to autoimmune thyroid disease susceptibility, extending the BLK locus associations beyond the traditional SLE/RA/Sjögren's disease spectrum.

The evidence base for rs4840568 specifically is thinner than for rs13277113 — four studies versus twenty-four — and the independence of the rs4840568 signal from the rs13277113 haplotype has not been established. Given the strong LD between the two variants in Asian populations, the practical clinical implication is similar: elevated background risk for B-cell-driven autoimmune disease, with monitoring as the primary action.

Practical Implications

Carriers of the A allele at rs4840568 are likely also carrying the A allele at rs13277113 in the same chromosomal segment, particularly if they are of Asian ancestry. The combined risk profile of the BLK locus — elevated in individuals with A alleles at multiple BLK region SNPs — centers on a modestly increased lifetime risk for systemic lupus erythematosus, and potentially for autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis). These are treatable conditions with excellent outcomes when detected early.

There are no proven dietary supplements or pharmacological preventions for BLK-mediated autoimmune predisposition. The actionable response is symptom awareness and access to appropriate screening.

Interactions

rs4840568 and rs13277113 are in strong LD (r²>0.9 in East Asian populations) and are likely co-inherited as part of the same BLK risk haplotype in most individuals. Their combined presence on a single chromosome is the unit of risk rather than independent additive contributions. The broader BLK-BANK1 interaction documented for rs13277113 is expected to apply equally to rs4840568 carriers, since the same haplotype block is implicated in both studies.

For individuals with rs4840568 AA genotype who also carry risk alleles at BANK1 rs1051648799 BANK1 rs10516487
BANK1 R61H variant in B-cell scaffold protein; synergistic with BLK variants for Sjögren's syndrome risk (OR=2.36 combined), the combined risk for primary Sjögren's syndrome is substantially elevated beyond either variant alone.

Genotype Interpretations

What each possible genotype means for this variant.

GG Typical BLK Region Normal

Common genotype — typical BLK locus activity

You carry two copies of the common G allele at rs4840568. This is the reference genotype at this upstream BLK regulatory position, associated with normal BLK expression levels in B cells and typical B-cell tolerance signaling. Approximately 45% of people globally share this genotype, with higher frequency in European (~73%) and Ashkenazi Jewish (~80%) populations and lower frequency in East Asian populations (~29%). Your genetic background risk for BLK-locus-associated autoimmune diseases is at or below the population average.

AG One Risk Allele Intermediate

One BLK upstream risk allele — modestly elevated autoimmune risk

rs4840568 sits 2kb upstream of the BLK transcription start site in the FAM167A-BLK regulatory locus on chromosome 8p23.1. It is in strong linkage disequilibrium with rs13277113 (r²>0.9 in Han Chinese populations), meaning that carrying the A allele at this position almost certainly means you also carry the A allele at rs13277113 — the more extensively studied BLK risk variant. The combined risk haplotype is associated with reduced BLK mRNA levels in B cells and impaired B-cell tolerance.

The heterozygous state confers approximately half the per-allele risk of the homozygous AA genotype under an additive model. For SLE this translates to approximately 1.15–1.20× elevated risk compared to the GG genotype. The SLE association is most robustly replicated in Asian populations, where the A allele is more frequent (East Asian A freq ~70%). An additional association with autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) has been reported in adolescent Chinese cohorts, extending the clinical relevance of this locus beyond classical SLE.

AA Two Risk Alleles High Risk

Two BLK upstream risk alleles — elevated autoimmune susceptibility

The homozygous AA genotype represents the full-risk end of the BLK upstream regulatory spectrum. Carriers of AA at rs4840568 are very likely to also carry AA at rs13277113 (the two sites are in strong LD, r²>0.9 in East Asian populations), meaning the BLK expression reduction associated with the risk haplotype is maximally present. BLK expression studies in SLE patients show approximately 0.52-fold reduction in BLK mRNA compared to controls, impairing the bone-marrow B-cell tolerance checkpoint that normally eliminates self-reactive clones before they can enter circulation.

The A allele frequency at rs4840568 is notably higher than at rs13277113 in Latino populations (A freq ~0.48–0.60 vs ~0.54) and African populations (A freq ~0.34 vs ~0.12 for rs13277113). This discrepancy suggests that in non-Asian populations, the two sites may not be fully correlated, and rs4840568 may tag a distinct haplotypic background in these groups. The functional consequence of this population-specific LD pattern is not fully characterized.

The additional autoimmune thyroid disease association (Graves' disease and Hashimoto's thyroiditis) documented in Song et al. 2018 is particularly relevant for East Asian individuals with the AA genotype, where this variant is especially prevalent. Thyroid autoimmunity is approximately 5–10× more common than SLE in the general population, making this an important additional surveillance target.